Labshake search
Citations for Invivogen :
151 - 200 of 1467 citations for 7 hydroxy 1H 1 2 4 triazolo 1 5 a pyrimidin 5 one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2020Quote: ... and 1:1,000 (vol/ vol) primocin (Invivogen, ant-pm-2).
-
The G2-phase enriched lncRNA SNHG26 is necessary for proper cell cycle progression and proliferationbioRxiv - Molecular Biology 2021Quote: ... we added 2 μg/ml puromycin (Invivogen, ant-pr-1) to the growth media 24 hours after transduction ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 100 μg ml-1 Primocin (#ant-pm-2; InvivoGen). NMR culture media was further supplemented with 1X non-essential amino acids (#11140-050 ...
-
bioRxiv - Immunology 2023Quote: ... or 2 µg/ml poly(dA:dT) (Invivogen, tlrl-patn-1) by using Lipofectamine 2000 for 6 hr ...
-
bioRxiv - Immunology 2024Quote: 2’-3-cyclic GMP-AMP (cGAMP) (tlrl-nacga23-1, InvivoGen) was added at 10μg/mL with or without 4μM H151 (inh-h151 ...
-
bioRxiv - Cell Biology 2022Quote: ... one day post-transfection cells were treated with 1 μg poly(I:C) HMW (InvivoGen, San Diego, CA) and 1 μg/mL dox per well ...
-
bioRxiv - Immunology 2021Quote: ... Cells reconstituted with pLenti CMVie-IRES-BlastR-based constructs were maintained with addition of 5 µg/ml and 1 µg/ml blasticidin (InvivoGen, Cat. no: ant-bl-05) for HEK293T and iBMDMs ...
-
bioRxiv - Immunology 2022Quote: ... immunogen suspensions were gently mixed 1:1 vol/vol with AddaVax adjuvant for immunizations 1 and 2 and O/W for immunization 3 (Invivogen, San Diego, CA) to reach a final concentration of 0.250 mg/mL antigen ...
-
bioRxiv - Systems Biology 2020Quote: ... followed by 5 hours with 200ng/ml LPS (Invivogen).
-
bioRxiv - Cell Biology 2021Quote: ... and 5 µg/ml Plasmocin (Cat# ant-mpp, InvivoGen), in a 37°C ...
-
bioRxiv - Cancer Biology 2022Quote: ... or Blasticidin (5-10 µg/ml; Invivogen; ant-bl).
-
bioRxiv - Immunology 2022Quote: ... and R848 (#tlrl-r848-5) were purchased from Invivogen. Sendai virus (SeV ...
-
bioRxiv - Immunology 2022Quote: ... 5 μg HA protein combined with either Alum (InvivoGen) or AddaVax (InvivoGen ...
-
bioRxiv - Cancer Biology 2019Quote: ... and 5 μg/ml Blasticidin (InvivoGen, ant-bl-10p). For the EWS-FLI1 shRNA induction ...
-
bioRxiv - Immunology 2021Quote: ... at 5 μM or the STING agonist cGAMP (Invivogen) or the TLR3 agonist polyinosinic-polycytidylic acid (poly(I:C) ...
-
bioRxiv - Biochemistry 2022Quote: ... and 50 μg/ml Zeocin (Invivogen, #ant-zn-5). MEFs were grown in DMEM containing 10% (v/v ...
-
bioRxiv - Cell Biology 2022Quote: ... Antibiotic concentrations used were: 5 μg/mL blasticidin (InvivoGen), 200 μg/mL hygromycin (Merck) ...
-
bioRxiv - Immunology 2022Quote: ... 5’ppp dsRNA was purchased from Invivogen (tlrl-3prna). 5’-di- and triphosphate ssRNA oligonucleotides were synthesized as previously described (Goubau et al. ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were selected in puromycin (5 µg/ml, InvivoGen) for 48h ...
-
bioRxiv - Evolutionary Biology 2023Quote: ... and 5 μg/ml plasmocin (InvivoGen, San Diego, CA), and cells were cultured in a humidified incubator with 5% CO2 at 37 °C ...
-
bioRxiv - Biophysics 2023Quote: ... and 5 mg/ml blasticidin (Invivogen #ant-bl-5b) at 37 °C ...
-
bioRxiv - Biochemistry 2023Quote: ... for two weeks or 5 μg/ml Puromycin (Invivogen) for 5 days to establish stable cell lines expressing the desired shRNA or sgRNA ...
-
bioRxiv - Bioengineering 2024Quote: ... and 100 µg/mL G418 (InvivoGen, ant-gn-5). For both mouse and human podocytes ...
-
bioRxiv - Immunology 2024Quote: ... supplemented every 48 hours with MCC950 (5 μM, Invivogen). NLRP3 inflammasome activation by Nigericin in BMDMs required a priming step where BMDMs were incubated with LPS (10 ng/ml ...
-
bioRxiv - Cell Biology 2024Quote: ... and 5 ug/ml plasmocin prophylactic (Invivogen, ant-mpp). hTERT-RPE1 and derived cells were cultured in a 1:1 mixture of Dulbecco’s Modified Eagle’s Medium (DMEM ...
-
bioRxiv - Immunology 2022Quote: ... for 3 hr followed by (flagellin isolated from P. aeruginosa, 2 or 5 µg/mL) for 3 hr using FLA-PA Ultrapure (InvivoGen, tlrl-pafla) according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2021Quote: ... in a final volume of 100 µL X-VIVOTM-15 + 2% HS + 1 µg.mL-1 poly(I:C) (tlrl-picw, Invivogen). After 3 h ...
-
Endothelial transmigration hotspots limit vascular leakage through heterogeneous expression of ICAM1bioRxiv - Immunology 2022Quote: ... a 2-day 1.5 μg/mL puromycin (InvivoGen, ant-pr-1) selection was performed ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 1% Penicillin/Streptomycin and 0.1mg/mL Normocin (ant-nr-2, Invivogen). HEK-Blue selection (hb-sel Invivogen ...
-
bioRxiv - Genetics 2022Quote: ... supplemented with 100 μg ml−1 primocin (Invivogen, ant-pm-2), 10% BIT 9500 (Stemcell Technologies ...
-
SMDT1 variants impair EMRE-mediated mitochondrial calcium uptake in patients with muscle involvementbioRxiv - Genetics 2022Quote: ... blasticidin (2 μg/ml; # ant-bl-1; InvivoGen, San Diego, USA) was added to the medium to select for stably transduced SMDT1-V5 or GFP-V5 cells ...
-
bioRxiv - Genetics 2023Quote: ... supplemented with 100 μg ml−1 primocin (Invivogen ant-pm-2), 10% BIT 9500 (Stemcell Technologies 09500) ...
-
bioRxiv - Molecular Biology 2021Quote: ... or on solid YPD-agar (1% yeast extract, 2% peptone, 2% D-glucose, 2% agar) and selected with 100 µg/ml Zeocin® (InvivoGen). For small scale expression screening ...
-
bioRxiv - Immunology 2020Quote: Undifferentiated THP-1 and PMA-differentiated cells (2 × 105 cells) in biological duplicates per condition were stimulated with TLR agonists- CL075 (TLR8; tlrl-c75; Invivogen, 5 μg/ml), CpG2006 (TLR9 ...
-
bioRxiv - Microbiology 2023Quote: ... The cells were cultured for 2 weeks in the presence of 1 µg/mL puromycin (ant-pr-1, InvivoGen). The cells were single-cell-cloned using a limiting dilution method ...
-
bioRxiv - Molecular Biology 2021Quote: ... the cells were treated with puromycin (5 mg/ml) (Invivogen) for two days to select for transfected cells ...
-
bioRxiv - Immunology 2019Quote: ... 0.9% saline or 5 mg/kg LPS (InvivoGen, tlrl-3pelps) was prepared as described above and administered by i.p ...
-
bioRxiv - Microbiology 2020Quote: ... These cells were selected with 5 μg/ml Blasticidin (Invivogen) for 3-5 days and then with 10 μg/ml Blasticidin for an additional 1-2 days ...
-
bioRxiv - Microbiology 2021Quote: ... adjuvanted with MPLA-AddaVax (Per animal: 5 μg MPLAs, InvivoGen, cat# vac-mpls ...
-
bioRxiv - Molecular Biology 2022Quote: ... or 5′ppp-dsRNA (2500 ng/well; InvivoGen, tlrl-3prna), or 3p-hpRNA (Invivogen ...
-
bioRxiv - Microbiology 2022Quote: ... selection was performed with 5 μg/ml blasticidin S (InVivoGen). Unless otherwise noted ...
-
bioRxiv - Cell Biology 2022Quote: ... and BX-795 (used at 5 μM) were from InvivoGen.
-
bioRxiv - Immunology 2022Quote: ... 50 μg/ml streptomycin and 5 mg/ml blasticidin (InvivoGen). All cell lines were maintained at 37°C at 5% CO2 incubator ...
-
bioRxiv - Molecular Biology 2022Quote: ... Cells were selected under 5 μg/ml Blasticidin-S (Invivogen) for two weeks.
-
bioRxiv - Cancer Biology 2023Quote: ... dsRNA treatment was performed by transfecting 5’-ppp-dsRNA (Invivogen) at a final concentration of 0.5 µg/mL using RNAiMax (Life Technolongies ...
-
bioRxiv - Molecular Biology 2023Quote: ... 5 μg/ml of blasticidin (InvivoGen, San Diego, CA, USA)) ...
-
bioRxiv - Cancer Biology 2021Quote: ... for 10 days or 2 μg/mL puromycin (InvivoGen; #ant-pr-1) for 4 days to generate stable cell lines.
-
bioRxiv - Biochemistry 2022Quote: ... cells were selected with 2 μg/mL puromycin (Invivogen: ant-pr-1).
-
bioRxiv - Physiology 2023Quote: ... and 1% normocin antibiotic (ant-nr-2, Invivogen, San Diego, CA, USA) at 20% oxygen (5% CO2 ...
-
bioRxiv - Microbiology 2024Quote: ... samples were mixed with a 1/10th volume of Alhydrogel (2%, InvivoGen) and agitated for 30 min ...